Frat is a phosphatidylinositol 3-kinase/akt-regulated determinant of glycogen synthase kinase 3β subcellular localization in pluripotent cells

Molecular and Cellular Biology

Volumn 32, Issue 2, 2012, Pages 288-296

  Bechard, Matthew ^a,b,c   Trost, Robert ^a,b   Singh, Amar M ^a,b   Dalton, Stephen ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of Georgia ^*  (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AXIN; BETA CATENIN; BINDING PROTEIN; FRAT 1 PROTEIN; FRAT 2 PROTEIN; FRAT 3 PROTEIN; FRAT PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISSOCIATION; EMBRYONIC STEM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN BINDING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; EMBRYONIC STEM CELLS; GLYCOGEN SYNTHASE KINASE 3; MICE; MUTATION; NEOPLASM PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; PLURIPOTENT STEM CELLS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84863420854     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05372-11     Document Type: Article

References (22)

1. Bechard M, Dalton S. 2009. Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal. Mol. Cell. Biol. 29:2092-2104.
2. Brunet A, et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857- 868.
3. Cartwright P, et al. 2005. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896.
4. Cong F, Varmus H. 2004. Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc. Natl. Acad. Sci. U. S. A. 101:2882-2887.
5. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR. 2007. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/betacatenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12:957-971.
6. Franca-Koh J, Yeo M, Fraser E, Young N, Dale TC. 2002. The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP. J. Biol. Chem. 277:43844-43848.
7. Fraser E, et al. 2002. Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J. Biol. Chem. 277:2176 -2185.
8. Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A. 1997. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. EMBO J. 16:441- 450.
9. Jonkers J, et al. 1999. In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3. Mech. Dev. 88:183-194.
10. Kelly KF, et al. 2011. Beta-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell 8:214 -227.
11. Kimelman D. 14 January 2005. Frat1. UCSD-Nat. Mol. Pages. http://www.signalinggateway.org/molecule/query?afcsid_A000956.
12. Meares GP, Jope RS. 2007. Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis. J. Biol. Chem. 282:16989 -17001.
13. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10:55-63.
14. Silva J, et al. 2008. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6:e253.
15. Smith KN, Singh AM, Dalton S. 2010. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7:343-354.
16. Storm MP, et al. 2007. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J. Biol. Chem. 282:6265-6273.
17. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663- 676.
18. van Amerongen R, et al. 2005. Frat is dispensable for canonical Wnt signaling in mammals. Genes Dev. 19:425- 430.
19. van Amerongen R, et al. 2010. Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways. Oncogene 29:93-104.
20. van der Houven van Oordt CW, et al. 1998. X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the cooperating molecular events. Carcinogenesis 19:847- 853.
21. Voskas D, Ling LS, Woodgett JR. 24 November 2010, posting date. Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling? F1000 Biol. Rep. 2:82. doi:10.3410/B2-82.
22. Wiechens N, Heinle K, Englmeier L, Schohl A, Fagotto F. 2004. Nucleocytoplasmic shuttling of Axin, a negative regulator of the Wnt-betacatenin pathway. J. Biol. Chem. 279:5263-5267.